Press Releases Ypsomed Group

Burgdorf – Austrian specialist pharmaceutical company, Ever Pharma, now offers the D-mine Pen for the treatment of Parkinson patients with apomorphine. This reusable pen, which is based on the Ypsomed ServoPen platform, facilitates subcutaneous administration with its patient friendly design.

Press Releases Ypsomed Group

Burgdorf – Michael Zaugg will join the Executive Management of the Ypsomed Group in mid-April 2017 and take on the role of Senior Vice President Human Resources. He will succeed Yvonne Müller, who is leaving Ypsomed at her own request.

Press Releases Ypsomed Group

Burgdorf – The shareholders of Ypsomed Holding AG approved all proposals by the board of directors by a large majority at the regular general meeting held on 29 June 2016. For the past 2015/16 business year, a dividend of CHF 1.00 per share, exempt from withholding tax, will be paid to shareholders from reserves arising from capital contributions.

Burgdorf – To deliver innovative care solutions, that improve the lives of people with diabetes, is the focus of the collaboration between Ypsomed and Novo Nordisk: Ypsomed’s own developed insulin pump mylife YpsoPump is fully compatible with NovoRapid PumpCart by Novo Nordisk.

Press Releases Ypsomed Group

Burgdorf – What began by establishing the Décolletage AG company 100 years ago and was continued from 1994 as a company within the Disetronic/Ypsomed Group is now Ypsotec: an internationally operating and successful vendor in the fields of precision engineering and medical technology with over 160 employees in Europe. Ypsotec AG will be celebrating its long and successful company history at a number of events.